Sudeep Pharma

SUDEEPPHRM

Q: Is the debt of Sudeep Pharma increasing or decreasing?

The net debt of Sudeep Pharma is decreasing.Latest net debt of Sudeep Pharma is ₹31.26 Crs as of Mar-25.This is less than Mar-24 when it was ₹46.96 Crs.

Q: Is Sudeep Pharma stock expensive?

There is insufficient historical data to gauge this.Latest PE of Sudeep Pharma is 0

Price

Market Cap

₹8,739 Cr.

New to Zerodha? Sign-up for free.

Sudeep Pharma Limited, incorporated in 1989, is a global manufacturer of pharmaceutical excipients, food-grade minerals and specialty nutrition ingredients. It runs extensive facilities, offers a wide product portfolio and maintains strong R&D capabilities.

Sudeep Pharma Limited, incorporated in 1989, is a global manufacturer of pharmaceutical excipients,… More

Low

725

52W Range

High

795

63.01

Sector PE

24.47

P/B

17.72

Div.Yield

ROE

28.13%

EBIDTA

ROCE

35.0

EPS

New to Zerodha? Sign-up for free.

Share Price
Financials
Revenue mix
Shareholdings
Peers
Forensics

This data is currently unavailable for this company.

Summary
Profit & Loss
Balance sheet
Cashflow

Yearly | Quarterly

View Detailed Summary

This data is currently unavailable for this company.

Yearly | Quarterly

(In Cr.)

(In Cr.)
This data is currently unavailable for this company.

Financial Ratio's

(In %)

Detailed P&L Report

(In Cr.)

Detailed Balance Sheet

Financial Year (In Cr.)

Detailed Cash Flow

Product wise
Location wise

SUDEEPPHRM
Revenue Mix

Latest

Historic

This data is currently unavailable for this company.

SUDEEPPHRM
Revenue Mix

Latest

Historic

This data is currently unavailable for this company.

More Info

Shareholdings

Holders

Detailed Shareholdings

This data is currently unavailable for this company.

Peers

Detailed Peers

Forensics

View Detailed Forensics

Recent events

News
Corporate Actions

This data is currently unavailable for this company.

More Market Cap Ideas

See similar 'Market' cap companies with recent activity

Popular questions

Business
Financials
Share Price
Shareholdings

What does Sudeep Pharma do?

Sudeep Pharma along with its subsidiary companies is engaged in business of manufacturing of excipients and specialty ingredients for the pharmaceutical, food and nutrition industries and is dedicated to contributing to the global healthcare ecosystem by providing excipients and specialty ingredients. It develops solutions that enhance vitality, functionality, and efficiency in consumer products.

Who are the competitors of Sudeep Pharma?

Sudeep Pharma major competitors are Blue Jet Healthcare, Anlon Healthcare, Acutaas Chemicals, Kronox Lab Sciences. Market Cap of Sudeep Pharma is ₹0 Crs. While the median market cap of its peers are ₹5,434 Crs.

Is Sudeep Pharma financially stable compared to its competitors?

Sudeep Pharma seems to be less financially stable compared to its competitors. Altman Z score of Sudeep Pharma is 0 and is ranked 5 out of its 5 competitors.

Does Sudeep Pharma pay decent dividends?

The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Sudeep Pharma latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

How has Sudeep Pharma allocated its funds?

Companies resources are allocated to majorly unproductive assets like Inventory

How strong is Sudeep Pharma balance sheet?

Sudeep Pharma balance sheet is weak and might have solvency issues

Is the profitablity of Sudeep Pharma improving?

Yes, profit is increasing. The profit of Sudeep Pharma is ₹139 Crs for Mar 2025, ₹133 Crs for Mar 2024 and ₹62.32 Crs for Mar 2023

Is the debt of Sudeep Pharma increasing or decreasing?

The net debt of Sudeep Pharma is decreasing. Latest net debt of Sudeep Pharma is ₹31.26 Crs as of Mar-25. This is less than Mar-24 when it was ₹46.96 Crs.

Is Sudeep Pharma stock expensive?

There is insufficient historical data to gauge this. Latest PE of Sudeep Pharma is 0

Has the share price of Sudeep Pharma grown faster than its competition?

There is not enough historical data for the companies share price.

Is the promoter bullish about Sudeep Pharma?

Promoters seem not to be bullish about the company and have been selling shares in the open market. Latest quarter promoter holding in Sudeep Pharma is 44.65% and last quarter promoter holding is 100.0%

Are mutual funds buying/selling Sudeep Pharma?

There is Insufficient data to gauge this.

SUDEEPPHRM

Share Price

Financials

Revenue mix

Shareholdings

Peers

Forensics

Summary

Profit & Loss

Balance sheet

Cashflow

Product wise

Location wise

Recent events

News

Corporate Actions

More Market Cap Ideas

Popular questions

Business

Financials

Share Price

Shareholdings

What does Sudeep Pharma do?

Who are the competitors of Sudeep Pharma?

Is Sudeep Pharma financially stable compared to its competitors?

Does Sudeep Pharma pay decent dividends?

How has Sudeep Pharma allocated its funds?

How strong is Sudeep Pharma balance sheet?

Is the profitablity of Sudeep Pharma improving?

Is the debt of Sudeep Pharma increasing or decreasing?

Is Sudeep Pharma stock expensive?

Has the share price of Sudeep Pharma grown faster than its competition?

Is the promoter bullish about Sudeep Pharma?

Are mutual funds buying/selling Sudeep Pharma?